Cardio Diagnostics Holdings, Inc. (CDIO) vs Sonoma Pharmaceuticals, Inc. (SNOA)
A side-by-side comparison of Cardio Diagnostics Holdings, Inc. and Sonoma Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CDIO
Cardio Diagnostics Holdings, Inc.
$2.03HealthcareDelayed quote: Oct 6, 2026, 2:43 PM EDT
SNOA
Sonoma Pharmaceuticals, Inc.
$1.21HealthcareDelayed quote: Oct 6, 2026, 2:29 PM EDT
Total return — CDIO vs SNOA
growth of $100 · dividends reinvested · last 5yCDIO -99.3% (-62.9%/yr)SNOA -98.7% (-57.9%/yr)SNOA compounded faster over this window
CDIO SNOA
CDIO vs SNOA: by the numbers
- •CDIO is the larger company ($6M vs $6M market cap).
- •Both run net losses; SNOA's is the smaller (-10.33% vs -44771.83% net margin).
Metrics side by side
Valuation
| Metric | CDIO | SNOA |
|---|---|---|
| P/S ratio | 415.76 | 0.26 |
| P/B ratio | 0.81 | 0.88 |
Profitability
| Metric | CDIO | SNOA |
|---|---|---|
| Gross margin | 100.00% | 38.91% |
| Operating margin | -43737.46% | -6.41% |
| Net margin | -44771.83% | -10.33% |
| ROE | -87.12% | -34.33% |
| ROIC | -82.84% | -10.98% |
Growth (annualized)
| Metric | CDIO | SNOA |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 5.79% |
| Total return CAGR (5Y) | N/A | -59.29% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.